Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marleen Boelaert

Showing results (11-20 of 260) with videos related to

Pageof 26
Sort By:
Expert Review of Anti-Infective Therapy|December 5, 2018
Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic reviewTemmy Sunyoto, Marleen Boelaert, Filip Meheus
Statistics in Medicine|June 14, 2008
Bayesian latent class models with conditionally dependent diagnostic tests: a case studyJoris Menten, Marleen Boelaert, Emmanuel Lesaffre
Plos Neglected Tropical Diseases|November 5, 2016
The Challenges of Conducting Clinical Research on Neglected Tropical Diseases in Remote Endemic Areas in SudanSayda El-Safi, François Chappuis, Marleen Boelaert
Lancet (London, England)|February 12, 2005
Antioxidant supplements for prevention of gastrointestinal cancersRodrigo Moreno-Reyes, Marleen Boelaert, Sylvain Meuris
Plos Neglected Tropical Diseases|March 8, 2013
Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphismsTapan Bhattacharyya, Marleen Boelaert, Michael A Miles
Lancet (London, England)|August 22, 2018
LeishmaniasisSakib Burza, Simon L Croft, Marleen Boelaert
Lancet (London, England)|March 7, 2019
Leishmaniasis - Authors' replySakib Burza, Simon L Croft, Marleen Boelaert
Tropical Medicine & International Health : TM & IH|October 24, 2006
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, IndiaFilip Meheus, Marleen Boelaert, Rob Baltussen, et al.
Expert Review of Anti-Infective Therapy|October 4, 2012
Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerableAlbert Picado, Suman Rijal, Shyam Sundar, et al.
JAMA|February 20, 2002
Do patents prevent access to drugs for HIV in developing countries?Marleen Boelaert, Lut Lynen, Wim Van Damme, et al.
Pageof 26

Showing results (11-20 of 260) with videos related to

Sort By:
Pageof 26
Expert Review of Anti-Infective Therapy|December 5, 2018
Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic reviewTemmy Sunyoto, Marleen Boelaert, Filip Meheus
Statistics in Medicine|June 14, 2008
Bayesian latent class models with conditionally dependent diagnostic tests: a case studyJoris Menten, Marleen Boelaert, Emmanuel Lesaffre
Plos Neglected Tropical Diseases|November 5, 2016
The Challenges of Conducting Clinical Research on Neglected Tropical Diseases in Remote Endemic Areas in SudanSayda El-Safi, François Chappuis, Marleen Boelaert
Lancet (London, England)|February 12, 2005
Antioxidant supplements for prevention of gastrointestinal cancersRodrigo Moreno-Reyes, Marleen Boelaert, Sylvain Meuris
Plos Neglected Tropical Diseases|March 8, 2013
Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphismsTapan Bhattacharyya, Marleen Boelaert, Michael A Miles
Lancet (London, England)|August 22, 2018
LeishmaniasisSakib Burza, Simon L Croft, Marleen Boelaert
Lancet (London, England)|March 7, 2019
Leishmaniasis - Authors' replySakib Burza, Simon L Croft, Marleen Boelaert
Tropical Medicine & International Health : TM & IH|October 24, 2006
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, IndiaFilip Meheus, Marleen Boelaert, Rob Baltussen, et al.
Expert Review of Anti-Infective Therapy|October 4, 2012
Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerableAlbert Picado, Suman Rijal, Shyam Sundar, et al.
JAMA|February 20, 2002
Do patents prevent access to drugs for HIV in developing countries?Marleen Boelaert, Lut Lynen, Wim Van Damme, et al.
Pageof 26